Search results
Showing 4141 to 4155 of 8905 results
Clarification on demonstrating patient access to medicines and treatments recommended by NICE Technology Appraisal (TA) or Highly Specialised Technologies (HST) guidance.
NICE has a key role in UK licensing and the evaluation of and access to new and innovative products for the health system.
Home What NICE does Our guidance About technology appraisal guidance {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":
Getting involved as a voluntary and community sector organisation
Getting involved with NICE as a voluntary and community sector organisation
The standing committees were responsible for the development of our public health guidance.
People can comment on our guidance at specific stages in its development.
Holding our meetings in public supports our commitment to having processes in place that are rigorous, open, and transparent.
Health inequalities can be experienced by people grouped by a range of different factors.
How to use NICE guidance to reduce health inequalities during and after pregnancy.
Health inequalities are differences in health across the population, and between different groups in society, that are systematic, unfair and avoidable.
Home News Articles {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/"
Home News...
Browse the complete list of all our published health and social care guidance, including guidelines, NICE advice and quality standards
Interim methods guide for developing good practice guidance (PMG15)
This interim methods guide is based on the general principles and methods included in other methods guides for developing NICE guidance
Interim clinical guideline surveillance process and methods guide 2013 (PMG16)
This guide outlines the main elements of the interim NICE clinical guideline surveillance process and methodology, which was agreed by the NICE Board in July 2013